Carvidon-MT Tablet ER

Introduction

Carvidon-MT ER is a prescription medication that contains two active ingredients: Trimetazidine and Metoprolol Succinate. Trimetazidine is a medication that helps improve blood flow to the heart, while Metoprolol Succinate is a beta-blocker that helps regulate heart rate and blood pressure.

Uses

Carvidon-MT ER is primarily prescribed to treat certain heart conditions, including angina pectoris, a condition characterized by chest pain or discomfort caused by reduced blood flow to the heart. It is also used to manage high blood pressure (hypertension) and to prevent future heart attacks in patients who have already experienced one.

Dosage and Administration

follow your healthcare provider’s instructions when taking Carvidon-MT ER. The dosage may vary depending on your specific condition and medical history. Typically, the recommended starting dose is one tablet taken orally once a day, preferably in the morning. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed.

Mechanism of Action

Trimetazidine in Carvidon-MT ER works by improving energy metabolism in heart cells, which helps the heart function more efficiently. Metoprolol Succinate, on the other hand, works by blocking certain receptors in the heart, reducing the heart’s workload and oxygen demand. Together, these two medications help improve blood flow to the heart and regulate heart rate and blood pressure.

Side Effects

Common side effects may include headache, dizziness, fatigue, and upset stomach. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as difficulty breathing, chest pain, or swelling of the face or throat, seek medical attention immediately.

Drug Interactions

Carvidon-MT ER may interact with other medications, including certain beta-blockers, calcium channel blockers, and medications used to treat high blood pressure or heart conditions. Inform your healthcare provider about all the medications you are currently taking to avoid any potential interactions. They will be able to determine if any adjustments to your medication regimen are necessary.

Precautions

Before taking Carvidon-MT ER, inform your healthcare provider about any allergies, medical conditions, or medications you are currently taking. This medication may not be suitable for everyone, especially those with certain heart conditions, asthma, or severe liver or kidney problems. Avoid alcohol while taking Carvidon-MT ER, as it may increase the risk of side effects.

Storage

Carvidon-MT ER should be stored at room temperature, away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Carvidon-MT ER exactly as prescribed by your healthcare provider. Do not change the dosage or stop taking the medication without consulting your doctor.
• continue taking the medication even if you feel well, as it helps manage your condition effectively.
• If you forget to take a dose, take it as soon as you remember. If it is close to the time for the next dose, skip the missed dose and resume your regular dosing schedule.
• Follow a healthy lifestyle, including a balanced diet, regular exercise, and stress management, to complement the effects of Carvidon-MT ER.
• Attend regular check-ups with your healthcare provider to monitor your condition and the effectiveness of the medication.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Metoprolol: medicine for high blood pressure (hypertension) (NHS UK) [Accessed 3 Jun. 2024] (online) Available at:
• Metoprolol (Drugs.com) [Accessed 11 Jun. 2024] (online) Available at:
• High Blood Pressure (Food and Drug Administration) [Accessed 13 Jun. 2024] (online) Available at:
• Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol. 2017 Sep;106(9):711-721. doi: 10.1007/s00392-017-1115-0. Epub 2017 Apr 22. [Accessed 2 Jun. 2024] Available at: